Authors: Yamanaka, R Zullo, SA Ramsey, J Onodera, M Tanaka, R Blaese, M Xanthopoulos, KG

Citation: R. Yamanaka et al., Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus, CANC GENE T, 8(10), 2001, pp. 796-802

Authors: Yamanaka, R Zullo, SA Tanaka, R Blaese, M Xanthopoulos, KG

Citation: R. Yamanaka et al., Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA, J NEUROSURG, 94(3), 2001, pp. 474-481

Authors: Liyanage, MS Xanthopoulos, KG

Citation: Ms. Liyanage et Kg. Xanthopoulos, Human DNA sequence polymorphisms: New opportunities for drug discovery andcustomized patient care, DRUG DEV R, 49(1), 2000, pp. 46-53

Authors: Lekstrom-Himes, J Xanthopoulos, KG

Citation: J. Lekstrom-himes et Kg. Xanthopoulos, CCAAT/enhancer binding protein epsilon is critical for effective neutrophil-mediated response to inflammatory challenge, BLOOD, 93(9), 1999, pp. 3096-3105

Authors: Muller, S Maas, A Islam, TC Sideras, P Suske, G Philipsen, S Xanthopoulos, KG Hendriks, RW Smith, CIE

Citation: S. Muller et al., Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1, BIOC BIOP R, 259(2), 1999, pp. 364-369